Pharmacological characterization of an epidermal growth factor receptor T790M mutation specific inhibitor (WZ8040)-resistant lung adenocarcinoma cells
碩士 === 國立陽明大學 === 生物藥學研究所 === 103 === Human non-small cell lung cancer (NSCLC) cells harboring epidermal growth factor receptor (EGFR) mutation are sensitive to EGFR tyrosine kinase inhibitors (EGFR-TKIs), such as Gefitinib (Iressa○R). However, lung cancer patients finally develop acquired resistanc...
| Main Authors: | , |
|---|---|
| Other Authors: | |
| Format: | Others |
| Language: | zh-TW |
| Published: |
2015
|
| Online Access: | http://ndltd.ncl.edu.tw/handle/81279517226709962729 |